Biogen Inc (BIIB) USD (CDI)
Share news, reports & tips
22 March 2019 14:23
(Sharecast News) - Trading on Wall Street has gotten off to a volatile start with weak German manufacturing figures sparking worries about global growth, sending traders scurrying for the relative safety of...
21 March 2019 15:13
(Sharecast News) - Biogen shares plummeted on Thursday after the company confirmed that it will cease clinical trials for aducanumab, the experimental Alzheimer's disease treatment it developed...
12 March 2019 16:49
(Sharecast News) - Biogen has entered into a share purchase agreement with Fujifilm Corporation, it announced on Tuesday, under which Fujifilm will acquire the shares of Biogen's subsidiary, which holds...
23 October 2018 13:33
(Sharecast News) - US biotech Biogen saw third-quarter profits come in ahead of analysts' estimates as a result of double-digit sales growth of its muscular atrophy treatment Spinraza.
8 July 2018 18:35
(Sharecast News) - A solid employment report for the month of June saw Wall Street shrug-off concerns around the potential for a ratcheting-up in protectionist measures around the world.
6 July 2018 14:35
(Sharecast News) - Biogen's shares soared on Friday after the company announced that one of the experimental Alzheimer's drugs it had developed with Japan's Eisai had succeeded in a mid-stage...
12 March 2018 12:52
(ShareCast News) - Biogen has agreed to buy a phase 2b trial-ready schizophrenia treatment from Pfizer for up to $590m.
Company announcements Announcements
No company announcements about Biogen Inc USD (CDI) were found.
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2020. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.